A control philosophy defines your organization’s vision for digitalization and helps your team align current and future technology-related decisions with that vision.
Read MoreThe difference between aseptic processing and terminal sterilization
Both aseptic processing and terminal sterilization remove contamination from drug products, but the two methods are not the same, and they are not interchangeable.
Read MoreFor efficient aseptic and sterile manufacturing, process architects are key
Designing an aseptic and sterile manufacturing facility that meets regulatory requirements takes expertise. Designing it to operate efficiently is even more challenging. Process architects are an important part of the team that can help you meet that challenge with confidence.
Read MoreWhat’s next for the life science industry?
Real talk from the front lines of today’s research and manufacturing landscape
Read MoreThe promise of RNA-based therapies
Decades of scientific progress in understanding the root cause of many formerly intractable diseases has opened up new treatment options, namely through RNA-based therapies. This second wave of biopharma, in which our understanding of the ways coding portions of our genome relate to disease, allows us to intercede earlier, and at more specific and effective junctures.
Read MoreThe top innovations in animal health pharmaceuticals manufacturing
As our lives become more entwined with animals’, their health becomes increasingly more important.
Read More6 trends shaping the plasma manufacturing industry
The top trends for plasma protein manufacturing are driven by a need to meet greater global demand in the face of a plasma shortage.
Read MoreThe dynamic future of life-saving medicine
Changing the way therapies work, and the changing work of making therapies.
Read MoreFill-finish in ATMP: 5 critical questions to ask on the way to process scale-up
To bring the exciting science of cell and gene therapy manufacturing to life, creating smaller-scale filling solutions is imperative to the success of the ATMP industry. But before you begin scaling your operation, there are important questions to consider about fill-finish in ATMP.
Read MorePartnering for speed: when global expertise meets local knowledge
Embracing the notion of a hybrid partner will support Europe-based life science innovators in delivering drug therapies faster and more cost-effectively.
Read More